← Latest papers
🛡️ immunology

Switch from inflammatory signaling to excessive extracellular matrix remodeling in fibrotic fibroblasts attenuates monocyte tissue infiltration

This study demonstrates that in advanced fibrosis, excessive activation of fibroblasts shifts their signaling from inflammatory cues to aggressive extracellular matrix remodeling, creating biomechanical barriers that physically restrict monocyte infiltration and migration within fibrotic tissues.

Original authors: de Winter, S., Neubert, E., Danen, E. H. J.

Published 2026-11-18
📖 5 min read🧠 Deep dive

Original authors: de Winter, S., Neubert, E., Danen, E. H. J.

Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). ⚕️ This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer

When the body suffers an injury, it launches a complex repair crew to fix the damage. This team includes specialized cells called fibroblasts, which act as the construction workers, laying down new structural materials to heal the wound. It also includes immune cells called monocytes, which travel from the blood into the tissue to clear out debris and fight infection. In a healthy healing process, these two groups work together seamlessly. However, sometimes this repair system goes into overdrive. Instead of stopping when the wound is fixed, the construction workers keep building, creating a thick, stiff scar that can eventually choke the organ and cause it to fail. This condition is known as fibrosis. A puzzling feature of advanced fibrosis is that while the scar tissue is dense and active, it often lacks the immune cells needed to regulate the process. Scientists have long wondered why these immune cells seem to vanish from the very areas where they are most needed, and whether the construction workers themselves are pushing them away.

A team of researchers at the Leiden Academic Centre for Drug Research in the Netherlands set out to solve this mystery by recreating the environment of a healing tissue in the laboratory. They grew human skin fibroblasts inside a three-dimensional gel made of collagen, the same protein that forms the scaffolding of our skin and organs. To this gel, they added human monocytes to see how the immune cells would behave. In their initial experiments, the researchers found that when fibroblasts were placed in this gel, they began to secrete chemical signals that acted like a beacon, drawing the monocytes deep into the gel. The fibroblasts also loosened the tight network of collagen fibers, creating larger spaces that made it easier for the monocytes to move through the tissue. In this state, the construction workers and the immune cells were working in harmony, with the fibroblasts actively inviting the immune cells in.

The story changed dramatically when the researchers introduced a specific growth factor known as TGF-beta 1, a molecule that is known to drive the formation of severe scars. When the fibroblasts were exposed to this factor, they underwent a profound transformation. They stopped producing the chemical signals that attracted the immune cells. Instead, they switched their focus entirely to remodeling the physical structure of the gel. They began to pull the collagen fibers together with great force and deposit new layers of protein, effectively tightening the meshwork around them. This shift meant that while the fibroblasts were still active, they were no longer calling for help; they were building a fortress.

To understand exactly how this affected the monocytes, the researchers designed a series of clever experiments. They first tested whether the fibroblasts were still chemically capable of attracting immune cells even after the transformation. Using a setup where cells could move toward a liquid containing the fibroblasts' secretions, they found that the transformed fibroblasts were still somewhat attractive, though less so than before. This suggested that the loss of attraction was only part of the story. The real barrier was physical. When the researchers placed monocytes on top of the gel containing the transformed fibroblasts, the immune cells simply could not get in. The surface of the gel had become so dense and tightly packed with fibers that it acted as an impenetrable wall. The monocytes were stuck on the outside, unable to cross the boundary to reach the fibroblasts inside.

The researchers then took this observation a step further by looking at what happened when fibroblasts were grouped together in clusters, mimicking the dense patches of scar tissue seen in human disease. They injected small groups of fibroblasts into the gel and watched how the surrounding collagen changed. When the fibroblasts were scattered, they created a network with large, open pores that allowed monocytes to move freely. However, when the fibroblasts were clustered together, their combined pulling force created a bridge of extremely dense material between them. When the researchers placed monocytes in the middle of these bridges, the immune cells found themselves trapped. They could not move through the tightly compressed fibers, effectively isolating them from the rest of the tissue.

These findings reveal a critical mechanism behind the immune silence often seen in advanced fibrosis. It is not that the immune cells are absent because the body has stopped trying to repair the tissue. Rather, the very cells responsible for repair, when pushed into a state of extreme activation, inadvertently build physical barriers that block the immune system from entering. The fibroblasts switch from a state of inviting cooperation to one of structural isolation. They stop sending out the chemical calls for help and instead construct a dense, impenetrable environment that keeps the immune cells at bay. This creates a self-perpetuating cycle where the scar tissue becomes increasingly isolated, preventing the immune system from regulating the repair process, which may explain why these conditions become so difficult to treat. The study suggests that in the late stages of fibrosis, the problem is not just too much scarring, but a specific type of scarring that physically excludes the body's own repair regulators.

Drowning in papers in your field?

Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.

Try Digest →